AMGN vs FSS · P/E 24, rev $10.05B vs P/E 32, rev $1.30B
Amgen Inc (AMGN) versus Federal Signal Corporation (FSS) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Federal Signal Corporation (FSS) is a pollution & treatment controls company listed on US.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported FSS revenue for 2026-06-30 was $1.30B. Net income was $156.5M. FSS currently screens at market cap $6.71B and trailing P/E 32.3.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. FSS currently screens at market cap $6.71B and trailing P/E 32.3.
Not investment advice. Open the AMGN and FSS stock pages for the full models.
Not investment advice.